Werewolf Therapeutics Inc (HOWL)

Apr 25, 2025

Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline - Yahoo Finance

Apr 25, 2025

Apr 25, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Friday - Defense World

Apr 25, 2025

Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform By Investing.com - Investing.com India

Apr 21, 2025

Apr 21, 2025

Werewolf Therapeutics stock maintains $4 target, Market Outperform - Investing.com

Apr 21, 2025

Apr 17, 2025

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire

Apr 17, 2025

Apr 17, 2025

Cancer Drug Developer Werewolf Therapeutics Strengthens Leadership Team Amid Promising Clinical Results - Stock Titan

Apr 17, 2025

Apr 17, 2025

Werewolf Therapeutics names Steven Bloom as CBO - The Pharma Letter

Apr 17, 2025

Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 By Investing.com - Investing.com South Africa

Apr 03, 2025

Mar 31, 2025

Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Werewolf Therapeutics Reveals Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 31, 2025

Bank of New York Mellon Corp Grows Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Mar 31, 2025

Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 - Investing.com India

Mar 26, 2025

Mar 18, 2025

Werewolf Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 18, 2025

Mar 18, 2025

HC Wainwright Issues Pessimistic Outlook for HOWL Earnings - Defense World

Mar 18, 2025

Mar 17, 2025

Wedbush Research Analysts Cut Earnings Estimates for HOWL - Defense World

Mar 17, 2025

Mar 14, 2025

HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025

Mar 14, 2025

Wedbush Reaffirms Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025

Mar 12, 2025

Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China - TipRanks

Mar 12, 2025

Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 11, 2025

Mar 11, 2025

Werewolf Therapeutics Inc. (HOWL) reports earnings - Quartz

Mar 11, 2025

Mar 11, 2025

Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c) - TipRanks

Mar 11, 2025

Mar 11, 2025

Werewolf Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025

Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - Bakersfield.com

Mar 11, 2025

Mar 11, 2025

HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Mar 11, 2025

Mar 04, 2025

Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewswire

Mar 04, 2025

Mar 04, 2025

What Will Werewolf Therapeutics Reveal at the Leerink Biopharma Conference Next Month? - StockTitan

Mar 04, 2025

Mar 01, 2025

Werewolf Therapeutics, Inc. Announces Board Changes and Committee Appointment - Marketscreener.com

Mar 01, 2025

Feb 28, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025

Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada

Feb 27, 2025

Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 - Investing.com

Feb 27, 2025

Feb 26, 2025

Werewolf Therapeutics Announces Board Resignation and New Appointment - Defense World

Feb 26, 2025

Feb 24, 2025

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Werewolf Therapeutics appoints new board member By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Werewolf Therapeutics appoints new board member - Investing.com India

Feb 24, 2025

Feb 24, 2025

Can This Oncology Pioneer Transform Werewolf's Cancer-Fighting Platform? - StockTitan

Feb 24, 2025

Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025

Feb 11, 2025

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 11, 2025

Feb 07, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - MarketBeat

Feb 07, 2025

Jan 28, 2025

Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World

Jan 28, 2025

Jan 24, 2025

Barclays PLC Increases Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jan 24, 2025

Jan 19, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 13.2% in December - MarketBeat

Jan 19, 2025